LOADING
Comparing NVIDIA Corporation (NVDA) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $4.31T | $182.6B |
| P/E Ratio | 36.2 | 27.7 |
| Forward P/E | 21.6 | 19.8 |
| PEG Ratio | 0.71 | 1.82 |
| EPS | $4.90 | $17.74 |
| Revenue Growth (YoY) | 73.2% | 7.2% |
| Profit Margin | 55.6% | 15.0% |
| Return on Equity | 101.5% | 13.0% |
| Dividend Yield | 0.02% | 0.35% |
| Beta | 2.33 | 0.97 |
| 52-Week High | $212.17 | $643.35 |
| 52-Week Low | $86.60 | $384.44 |
| Volume | -- | -- |
NVIDIA Corporation is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Thermo Fisher Scientific offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.